Press Releases

Wednesday Nov 01, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Can Diabetes, Weight-Loss Drugs Get Even Better?” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/q9osg It shouldn’t be surprising that analysts at Markets and Research estimate the global diabetes drug market at $63.1 billion in 2021 on its…

Wednesday Nov 01, 2023 - 9:00 am

Employee-Owned Brand Brings Sustainable Pre-Rolls to New York

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- The Honeybee Collective, a cannabis brand known for its commitment to a sustainable planet and people-friendly practices, will be available for purchase in New York starting Friday, Oct. 20, 2023. The brand first launched in 2021 after a record-breaking crowdfunding campaign and is available in 45 dispensaries across Colorado, where they’ve seen 28% average monthly growth in…

Tuesday Oct 31, 2023 - 10:30 am

HUB Cyber Security Signs an LOI to Acquire a Strategic Product Developer Cyber Security Company

TEL AVIV, Israel, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- HUB Cyber Security Ltd. (Nasdaq: HUBC), a developer of Confidential Computing cybersecurity solutions and services (“HUB'' or the “Company”), announces a strategic alliance LOI with a company with cutting-edge technology in the automation of cyber risk detection and responses. The LOI contemplates that both companies will engage in a strategic alliance via marketing the…

Tuesday Oct 31, 2023 - 9:15 am

European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot

Recently rebranded Scinai Immunotherapeutics shifted drug development focus from COVID-19 antibody to a novel antibody for the treatment of psoriasis and launched a CDMO business unit Adjusted terms being considered by EIB would extend maturity of finance facility and improve shareholders’ equity JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative…

Tuesday Oct 31, 2023 - 9:00 am

GEMXX Issues 2024 Roadmap, Expansion Plans and Milestones Update

LAS VEGAS, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- GEMXX Corporation (OTC: GEMZ) ("GEMXX" or the "Company"), a leader in the ammolite gemstone mine-to-market segment and a partner in Canadian gold exploration Company Crazy Horse Mining, Inc. (“CHMI” or “Crazy Horse”), is highlighting recent significant achievements to update new and existing investors prior to releasing quarter-end financial reporting. Current State - GEMXX has achieved significant milestones recently and…

Tuesday Oct 31, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand Portfolio @ IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Can Diabetes, Weight-Loss Drugs Get Even Better?”,please visit: https://nnw.fm/q9osg The prestigious…

Tuesday Oct 31, 2023 - 9:00 am

PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101

TARRYTOWN, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological disorders, announced today the successful acquisition of certain suramin research assets from Rediscovery Life Sciences (RLS). These assets were previously dedicated to the study of suramin's potential efficacy in treating acute kidney injury resulting from chronic kidney disease. The newly acquired…

Tuesday Oct 31, 2023 - 9:00 am

Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update

JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases, announced the publication today of its financial results for the third quarter ended Sept. 30, 2023 and provided a business update. THIRD QUARTER 2023 FINANCIAL SUMMARY R&D expenses for…

Monday Oct 30, 2023 - 1:45 pm

Electronic Servitor Publication Network, Inc. to Present at Emerging Growth Conference

MINNEAPOLIS, Oct. 30, 2023 (GLOBE NEWSWIRE) -- via IBN – Electronic Servitor Publication Network, Inc. (XESP), a digital engagement company and market disruptor, today announces it has been invited to present at the Emerging Growth Conference on Nov. 1, 2023. This live, interactive online event offers existing shareholders and the investment community an opportunity to interact with the company’s President and CEO, Peter Hager. Hager will provide…

Monday Oct 30, 2023 - 1:35 pm

Diamond Lake Minerals Inc. (DLMI) Welcomes Brian J. Esposito As Company CEO In Addition To Seven New Strategic Advisors

Brian J. Esposito, founder and CEO of Esposito Intellectual Enterprises, LLC., boasts 20 years of experience and a proven track record of driving growth and innovation Increase in Strong Advisory Board: Agnes Budzyn, Anthony Scaramucci, Larry Namer, Michael J. Malik Sr., Andrew Fromm, Brandon Fugal, and Raul Leal Newest board additions bring the company closer to its ultimate vision and further strengthen its competitive advantages,…

Monday Oct 30, 2023 - 11:45 am

PaxMedica Announces 1-for-17 Reverse Stock Split

TARRYTOWN, N.Y. , Oct. 30, 2023 (GLOBE NEWSWIRE) -- via IBN — PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (APT) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms, today announced that as a result of its 1-for-17 reverse stock split of its common stock that became effective at 8:03…

Monday Oct 30, 2023 - 9:00 am

Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023

Showcasing Scinai’s end-to-end cGMP Biologics CDMO services at booth 271 Pursuing partnerships for Scinai’s pipeline of novel VHH antibody-based therapies JERUSALEM, Oct. 30, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announces that it will be showcasing both its CDMO services, marketed under the brand Scinai Bioservices, and its in-house nanosized VHH antibody-based therapeutics pipeline at BIO-Europe, one of Europe’s premier pharmaceutical…

Thursday Oct 26, 2023 - 2:30 pm

AtomBeam Hits $600,000 Milestone in Ongoing StartEngine Campaign

MORAGA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- AtomBeam Technologies Inc., a technology company driving hyperefficient machine communication, has achieved a significant milestone by reaching the $600,000 mark in their ongoing fundraising campaign hosted on the StartEngine investment platform. AtomBeam Technologies’ capital raising campaign has seen one of the strongest openings on StartEngine recently, rapidly gaining the attention and support of investors.…

Thursday Oct 26, 2023 - 2:00 pm

PaxMedica’s Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication

TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to announce that the Annals of General Psychiatry, an internationally recognized scientific psychiatry publication, has accepted the manuscript titled "Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder" for publication. This groundbreaking research, authored by PaxMedica’s Chief Medical Officer,…

Thursday Oct 26, 2023 - 10:00 am

Astra Energy Inc., Sustainable Energy Technologies, Inc. and Holcomb Energy Systems LLC Are Joining at the Fort Lauderdale International Boat Show Sponsored by Camper and Moretti Yacht Group

SAN DIEGO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- Astra Energy Inc. (OTCQB: ASRE) (“Astra” or the “Company”) an innovative clean and renewable energy solution provider, together with Holcomb Energy Systems LLC (“HES”) and Sustainable Energy Technologies, Inc. (“SETI”), is exhibiting at the Fort Lauderdale International Boat Show (“FLIBS”), sponsored by Camper and Moretti Yacht Group, today through Oct. 29, 2023. FLIBS 2023 is the world’s largest boat show, promoting luxury,…

Thursday Oct 26, 2023 - 9:30 am

Mullen Receives Favorable Decision from Nasdaq Hearings Panel

BREA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today that the Nasdaq Hearings Panel (“Panel”) has granted Mullen’s request to continue its listing on The Nasdaq Capital Market, subject to the following conditions: on or before Jan. 22, 2024, the Company must demonstrate compliance with Listing Rule 5550(a)(2), by…

Wednesday Oct 25, 2023 - 9:00 am

IBN Announces Latest Episode of The Bell2Bell Podcast featuring Return of Mark Selby, CEO of Canada Nickel Company Inc.

LOS ANGELES, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s…

Tuesday Oct 24, 2023 - 9:00 am

HyperSense Software Expands Footprint with New Chicago Branch

CHICAGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via IBN - HyperSense Software, a renowned global provider of software development and digital transformation solutions, is excited to announce the opening of its new office in Chicago, marking a significant expansion in its United States presence. The move to Chicago demonstrates HyperSense’s commitment to bringing its unparalleled expertise closer to clients in diverse industries including fintech, healthcare,…

Tuesday Oct 24, 2023 - 9:00 am

GEMXX Corporation (GEMZ) Reports 2023 Gold Production at 100% of Target for the Snow Creek Test Mine Site in British Columbia, Canada

LAS VEGAS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via IBN / GEMXX Corporation (OTC: GEMZ) ("GEMXX" or the "Company"), a leader in the ammolite gemstone mine-to-market segment and a partner in Canadian gold exploration, is pleased to announce its collaboration with Crazy Horse Mining, Inc. (“CHMI” or “Crazy Horse”) has successfully completed its third and final clean-out and recording of gold production at the Snow Creek Mine site…

Tuesday Oct 24, 2023 - 9:00 am

Longeveron Inc. Featured in Syndicated Broadcast Highlighting Top-Line Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ for the Treatment of Mild Alzheimer’s

LOS ANGELES, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via IBN -- Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The…

Tuesday Oct 24, 2023 - 9:00 am

IBN Coverage Initiated for Diamond Lake Minerals Inc. (DLMI)

LOS ANGELES, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via IBN -- Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities, today announces it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Diamond Lake Minerals’ goal, through its established M&A roadmap, is to…

Monday Oct 23, 2023 - 10:00 am

A New Dawn in Retail: VenHub to Unveil the Alpha Smart Store at Sold-out Grand Opening

PASADENA, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- via IBN -- The moment has arrived. Mark your calendars, as Oct. 25, 2023, will go down in history as the day when VenHub shatters the glass ceiling of retail innovation. VenHub is not just launching a product; it is launching the future of retail at its grand opening in Pasadena, California. Imagine the impossible and prepare…

Monday Oct 23, 2023 - 9:00 am

Mullen Provides Update on Lawsuit Against TD Ameritrade, Charles Schwab, National Finance Services and Others

BREA, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today an update on the lawsuit the Company filed on Aug. 29, 2023, in the United States District Court (“Court”), in the Southern District of New York, against TD Ameritrade, Charles Schwab, National Finance Services and others alleging that those broker…